Ampakine Articles

Cortex could gain $3 million in Ampakine deal with Lab Servier

15 June 2011

Cortex reacquires all Ampakine compounds, IP and rights from Valeant; cuts loss

22 March 2011

Merck & Co returns Ampakine compounds rights to Cortex; signs antibacterials deal with BioRelix

5 October 2010

Cortex sells selected Ampakine compounds and rights to respiratory depression indication to Biovail for up to $25 million

29 March 2010

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end